Insider trading

Period: 120 months Stock: VNRX Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

44 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

44 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

44 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

44 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
44 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
44 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

44 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
22 Feb 2023
Innes Guy Archibald Director · indirect
Bought 4×
$409.50K 234,000 at 1.75
opened
19 Dec 2022
Micallef Jacob Vincent Chief Scientific Officer
Bought
$57.50K 25,000 at 2.30
15.3%
Largest buy in 3 yrs
19 Dec 2022
Butera Salvatore Thomas CEO - Volition Veterinary
Bought
$11.35K 5,000 at 2.27
10.8%
16 Dec 2022
Bought
$115.50K 55,000 at 2.10
3.5%
First buy on file
16 Dec 2022
Micallef Jacob Vincent Chief Scientific Officer
Bought
$14.38K 7,339 at 1.96
4.7%
12 Dec 2022
Butera Salvatore Thomas CEO - Volition Veterinary
Bought
$9.09K 4,350 at 2.09
10.4%
8 Dec 2022
Plummer Nicholas GC - Volition Diagnostics
Bought
$9.94K 4,800 at 2.07
10.3%
First buy on file
28 Nov 2022
Butera Salvatore Thomas CEO - Volition Veterinary
Bought
$11.05K 5,000 at 2.21
13.5%
19 Sep 2022
Micallef Jacob Vincent Chief Scientific Officer · indirect
Bought
$22.10K 13,000 at 1.70
59.1%
+59% of stake
30 Aug 2022
Reynolds Cameron John President and CEO
Bought
$5.64K 3,500 at 1.61
0.3%
First buy on file
26 Aug 2022
Micallef Jacob Vincent Chief Scientific Officer
Bought
$50.46K 29,000 at 1.74
24.1%
First buy on file
23 Aug 2022
Butera Salvatore Thomas CEO - Volition Veterinary
Bought
$8.00K 5,000 at 1.60
3.1%
22 Aug 2022
Butera Salvatore Thomas CEO - Volition Veterinary
Bought
$8.20K 5,000 at 1.64
3.2%
2 Aug 2022
Innes Guy Archibald Director · indirect
Bought 4×
$600.00K 300,000 at 2.00
opened
Largest buy in 3 yrs
2 Aug 2022
Bought
$25.00K 12,500 at 2.00
0.8%
16 Jun 2022
Butera Salvatore Thomas CEO - Volition Veterinary
Bought
$20.50K 10,000 at 2.05
6.9%
6 Jun 2022
TERRELL JASON BRADLEY MD Chief Medical Officer
Sold, plan not stated
$36.92K 14,949 at 2.47
54.9%
Sold half or more
16 May 2022
Bought
$23.70K 10,000 at 2.37
0.7%
11 Apr 2022
TERRELL JASON BRADLEY MD Chief Medical Officer
Sold, plan not stated
$27.50K 10,000 at 2.75
26.8%
16 Nov 2021
Butera Salvatore Thomas CEO-Volition Veterinary
Bought
$40.20K 10,000 at 4.02
opened
First buy on file
28 May 2021
TERRELL JASON BRADLEY MD Chief Medical Officer
Sold, plan not stated
$35.40K 10,000 at 3.54
28.6%
17 May 2021
Bought
$173.50K 50,000 at 3.47
3.4%
14 May 2021
Bought
$329.00K 100,000 at 3.29
7.2%
First buy on file
14 May 2021
Nguyen Kim Director
Bought
$6.40K 2,000 at 3.20
400%
First buy on file
5 Feb 2021
TERRELL JASON BRADLEY MD Chief Medical Officer
Sold, plan not stated
$53.70K 10,000 at 5.37
22.2%
2 Dec 2020
TERRELL JASON BRADLEY MD Chief Medical Officer
Sold, plan not stated
$34.00K 10,000 at 3.40
18.2%
18 Nov 2020
TERRELL JASON BRADLEY MD Chief Medical Officer
Sold, plan not stated 2×
$11.51K 3,429 at 3.36
5.9%
17 Nov 2020
TERRELL JASON BRADLEY MD Chief Medical Officer
Sold, plan not stated
$5.34K 1,571 at 3.40
2.6%
15 Sep 2020
TERRELL JASON BRADLEY MD Chief Medical Officer
Sold, plan not stated
$62.99K 19,500 at 3.23
35.8%
9 Sep 2020
Sold, plan not stated
$208.65K 65,000 at 3.21
4.1%
22 May 2020
Reynolds Cameron John President and CEO
Bought
$11.00K 4,000 at 2.75
0.4%
First buy on file
5 Dec 2019
Reynolds Cameron John President and CEO
Bought
$4.66K 1,100 at 4.24
0.1%
First buy on file
1 Oct 2019
Eight Corp Ltd 10% owner · indirect
Bought
$284.57K 50,000 at 5.69
0.4%
First buy on file
26 Sep 2019
Eight Corp Ltd 10% owner · indirect
Sold, plan not stated
$278.79K 46,238 at 6.03
0.4%
27 Aug 2019
Bought
$37.50K 10,000 at 3.75
0.6%
First buy on file
15 Aug 2019
Bought
$197.00K 50,000 at 3.94
3.3%
First buy on file
11 Jun 2019
Bought 2×
$246.13K 79,269 at 3.11
5.6%
First buy on file
10 Jun 2019
Bought
$213.61K 70,731 at 3.02
5.2%
First buy on file
16 Aug 2018
Bought 4×
$99.99K 50,000 at 2.00
3.8%
First buy on file
16 Aug 2018
Reynolds Cameron John President and CEO
Bought
$12.42K 6,500 at 1.91
0.6%
First buy on file
16 Aug 2018
Bought
$9.55K 5,000 at 1.91
104%
First buy on file
19 Sep 2017
Vanston David Cecil CHIEF FINANCIAL OFFICER
Bought
$7.81K 2,750 at 2.84
opened
First buy on file
16 Aug 2017
Rootsaert Rodney Gerard Secretary · indirect
Bought
$10.06K 3,630 at 2.77
0.4%
First buy on file
16 Aug 2017
Reynolds Cameron John President and CEO · indirect
Bought
$10.06K 3,630 at 2.77
0.4%
First buy on file
Showing 1–44 of 44.